More equitable testing for prostate cancer risk is on the horizon, as researchers report findings from the largest and most genetically diverse study of prostate cancer genes ever conducted.

​Researchers have identified 11 new gene alterations that are linked to more aggressive prostate cancer which can be picked up with a simple blood test.

A new study sheds light on the genetic messages encoded by genes within ‘triple negative’ breast cancers – and poses important questions on how they could be better treated in future.